Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8648394 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Topotecan;   Drug: Fludarabine;   Drug: Cytarabine

Indicates status has not been verified in more than two years